Skip to main content

Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel

New York, New York·EIN 46-3673346·NTEE H99 · Medical Research·501(c)(3)·Filing year 2024

Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel's highest-paid officer, the Sanders Director, was reported at $696,150 for 2024 (IRS Form 990), including base pay and other compensation.

Total revenue
$16.6M
Total assets
$7.3M
Total expenses
$16.6M
Reported officers
16

How Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel’s pay compares

Compared with Medical Research organizations of similar size in the Middle Atlantic states.

There were too few similar organizations to compare with, so this group goes beyond New York.

Above peers

Most of the roles Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel reports are paid above the middle half of what these Medical Research organizations pay for the same roles.

Show how each role compares

From the officer pay Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel reported on its latest IRS Form 990.

TO FURTHER AND IMPROVE HEALTH AND THE DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASE THROUGH RESEARCH, GENERATE INNOVATIVE PROOF-OF-CONCEPT STUDIES, AND ADVANCE THE SCIENTIFIC ACTIVITIES OF THE CONTROLLING INSTITUTIONS. (CONTINUED ON SCHEDULE O)THE SANDERS TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE, INC. WAS ORGANIZED AND IS OPERATED AS AN INDEPENDENT, NON-PROFIT CORPORATION, CONTROLLED BY LEADING NOT-FOR-PROFIT ACADEMIC, MEDICAL AND RESEARCH INSTITUTIONS, TO FURTHER AND IMPROVE HEALTH AND THE DIAGNOSIS, PREVENTION AND TREATMENT OF DISEASE THROUGH TRANSLATIONAL RESEARCH, GENERATE INNOVATIVE PROOF-OF-CONCEPT STUDIES, AND ADVANCE THE SCIENTIFIC ACTIVITIES OF THE CONTROLLING INSTITUTIONS (MEMORIAL SLOAN KETTERING CANCER CENTER, THE ROCKEFELLER UNIVERSITY, AND WEILL CORNELL MEDICAL COLLEGE) FACULTY, FELLOWS AND STUDENTS IN ASPECTS OF TRANSLATIONAL RESEARCH, CHEMISTRY, PHARMACOLOGY, AND DRUG DISCOVERY.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 16 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Medical Research organizations of similar size in the Middle Atlantic states. There were too few similar organizations to compare with, so this group goes beyond New York.

Sanders Director
Above 75th percentileOn the typical range for this role
$696k
Base
$502k
Bonus
$126k
Other
—
Benefits
$35k
Vice President, Biologics
Board Vice President
$475k
Base
$324k
Bonus
$79k
Other
—
Benefits
$38k
Vice President, Oprations
Board Vice President
$361k
Base
$219k
Bonus
$81k
Other
—
Benefits
$27k
Vice President, Chemistry
Board Vice President
$351k
Base
$243k
Bonus
$47k
Other
—
Benefits
$27k
Board Member
$342k
Sr. Director
Highest Compensated Employee
Above 75th percentileOn the typical range for this role
$342k
Base
$245k
Bonus
$36k
Other
—
Benefits
$28k
Vice President, Finance
Board Vice President
$302k
Base
$216k
Bonus
$40k
Other
—
Benefits
$14k
Board Member
$285k
Treasurer
Below 10th percentile
$145k
Board Member
$138k
Board Member
$124k
Board Member
$85k
Board Member
$72k
Board Member
$69k
Board Member
$50k
Board Member
$44k

Browse compensation in Medical Research →

Top pay as a share of expenses

In 2024, the highest total compensation at Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel equaled 4% of the organization's total expenses. The median for medical research organizations is 10%.

This organization (2024)
4%
Sector median
10%
Middle half of sector
4% to 21%

Based on 1,115 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.

Up 2%
from 2023

From $681k in 2023 to $696k in 2024.

$681k
2023
$696k
2024
Pay for the position

Director (Operational) pay rose 2% from 2023 to 2024, while revenue fell 11%.

$681k in 2023 to $696k in 2024.
  • Board Vice President pay rose 3% from 2023 to 2024.
  • Board Member pay rose 24% from 2023 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Common questions about Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel

What does the Director (Operational) of Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel earn?

In 2024, the Director (Operational) of Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel received $696,150 in total compensation. This pay is above the typical range for Director (Operational) roles, the same range the role page shows for organizations like this one: over the 75th percentile of that range.

What are Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel's revenue and expenses?

In 2024, Sanders Tri-Institutional Therapeutics Discovery Institute Inc Co Weill Cornel reported $16.6M in total revenue and $16.6M in total expenses on its IRS Form 990.